HIV in injecting drug users in Asian countries: Naltrexone implants are set to supersede harm minimisation

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7483.147 (Published 13 January 2005) Cite this as: BMJ 2005;330:147
  1. Albert S Reece, general practitioner (sreece@bigpond.net.au)
  1. Brisbane, QLD 4101, Australia

    EDITOR—Wodak et al draw attention to intravenous drug use as a source of HIV transmission.1 They make the case for harm minimisation strongly but omit to mention that this is consistent with ongoing and even increasing drug use.2 Harm minimisation remains a hypothesis that has never been shown to fulfil Hill's …

    View Full Text

    Sign in

    Log in through your institution